种族/族裔差异在冠心病孤立性干预的治疗选择与结局中持续存在
基于美国全国住院患者样本2002-2017年数据,分析种族/族裔在冠心病孤立性冠状动脉旁路移植术或经皮冠状动脉介入治疗选择及结局中的差异。调整混杂因素后,非洲裔患者接受冠状动脉旁路移植术的 odds 最低(OR 0.76),且冠状动脉旁路移植术后风险调整死亡率更高(OR 1.09),住院费用更高。
要点
- 非洲裔患者较白人更年轻、更多医疗补助保险、合并症更多(均P<.01)。
- 调整后非洲裔患者接受冠状动脉旁路移植术的 odds 最低(OR 0.76;P<.01)。
- 非洲裔患者冠状动脉旁路移植术后风险调整死亡率更高(OR 1.09;P<.01),经皮冠状动脉介入治疗后死亡率无差异。
核心结论
- 在这一当代全国分析中,冠心病接受冠状动脉旁路移植术 versus 经皮冠状动脉介入治疗的风险调整频率因种族/族裔而异。
- 非洲裔患者接受冠状动脉旁路移植术的 odds 更低且结局更差。
- 作者认为这些差异的原因值得进一步研究,以识别减少潜在差异的机会。
研究设计与样本
- 查询全国住院患者样本(National Inpatient Sample)中2002-2017年接受孤立性冠状动脉旁路移植术或经皮冠状动脉介入治疗的患者。
- 按种族/族裔(白人、非洲裔美国人、西班牙裔、亚裔)分层分析结局。
- 采用多变量 logistic 回归评估种族/族裔与接受冠状动脉旁路移植术 versus 经皮冠状动脉介入治疗、院内死亡率和费用之间的关联。
主要发现
- 15年间共进行2,426,917例孤立性冠状动脉旁路移植术和7,184,515例经皮冠状动脉介入治疗。
- 与白人患者相比,非洲裔患者更年轻(62 [四分位距,53-70] vs 66 [四分位距,57-75]岁),更可能有医疗补助保险(12.2% vs 4.4%),合并症更多(Charlson-Deyo指数,1.9 ± 1.6 vs 1.7 ± 1.6)(均P < .01)。
- 调整患者合并症、急性心肌梗死存在、保险状态和地理因素后,非洲裔患者在所有的种族/族裔组中最不可能接受冠状动脉旁路移植术(比值比,0.76;P < .01),这一趋势贯穿整个研究。
- 非洲裔患者冠状动脉旁路移植术后风险调整死亡率更高(比值比,1.09;P < .01)。
- 种族/族裔与经皮冠状动脉介入治疗后死亡率增加无关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Studies have noted racial/ethnic disparities in coronary artery disease intervention strategies. We investigated trends and outcomes of coronary artery disease treatment choice (coronary artery bypass grafting or percutaneous coronary intervention) stratified by race/ethnicity. METHODS: We queried the National Inpatient Sample for patients who underwent isolated coronary artery bypass grafting or percutaneous coronary intervention (2002-2017). Outcomes were stratified by race/ethnicity (White, African American, Hispanic, Asian). Multivariable logistic regression evaluated associations between race/ethnicity and receiving coronary artery bypass grafting versus percutaneous coronary intervention, in-hospital mortality, and costs. RESULTS: Over the 15-year period, 2,426,917 isolated coronary artery bypass grafting surgeries and 7,184,515 percutaneous coronary interventions were performed. Compared with White patients, African American patients were younger (62 [interquartile range, 53-70] vs 66 [interquartile range, 57-75] years), were more likely to have Medicaid insurance (12.2% vs 4.4%), and had more comorbidities (Charlson-Deyo index, 1.9 ± 1.6 vs 1.7 ± 1.6) (all P < .01). After adjustment for patient comorbidities, presence of acute myocardial infarction, insurance status, and geography, African Americans were the least likely of all racial/ethnic groups to undergo coronary artery bypass grafting (odds ratio, 0.76; P < .01), a consistent trend throughout the study. African American patients had higher risk-adjusted mortality after coronary artery bypass grafting (odds ratio, 1.09; P < .01). Race/ethnicity was not associated with increased mortality after percutaneous coronary intervention. African American patients had higher hospitalization costs for coronary artery bypass grafting (+$5816; P < .01) and percutaneous coronary intervention (+$856; P < .01) after controlling for confounders. CONCLUSIONS: In this contemporary national analysis, risk-adjusted frequency of coronary artery bypass grafting versus percutaneous coronary intervention for coronary artery disease differed by race/ethnicity. African American patients had lower odds of undergoing coronary artery bypass grafting and worse outcomes. Reasons for these differences merit further investigation to identify opportunities to reduce potential disparities.
引用
- Zea-Vera R, Asokan S, Shah RM, et al. Racial/ethnic differences persist in treatment choice and outcomes in isolated intervention for coronary artery disease. J Thorac Cardiovasc Surg. 2022. PMID: 35248359. doi:10.1016/j.jtcvs.2022.01.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。